User Fee Package Offers FDA Reforms From A House Wary Of FDA Power
Executive Summary
House drafters’ dissatisfaction with FDA’s performance is evident in several provisions of draft user fee legislation. The agency would be required to finalize some guidances within a year of issuing a draft, which likely would provide more predictability for industry.
You may also be interested in...
Did PDUFA V Pass Too Quickly?
The pending Supreme Court decision on the Affordable Care Act may have forced negotiators to finish quicker than they would have liked as legislators indicate some more time may have produced an agreement on track-and-trace standards; stakeholders may question whether the bill could have been improved had the deadline not been looming.
User Fee Conference Committee Targets Settling Differences In June
A conference committee tackles differences between House and Senate FDA user fee and agency reform bills, with an agreement expected before the end of June.
User Fee Conference Committee Targets Settling Differences In June
A conference committee tackles differences between House and Senate FDA user fee and agency reform bills, with an agreement expected before the end of June.